PhoreMost and ThinkCyte collaborate to advance AI based drug discovery
PhoreMost Ltd. and ThinkCyte K.K today announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI).
Source: news-medical.net